American CryoStem Corporation: American CryoStem Announces FDA Approval of IND to Commence Phase I Clinical Trial for Long COVID/Post-Acute Sequelae of SARS-CoV-2 (PASC)
Eatontown, New Jersey--(Newsfile Corp. - January 6, 2023) - American CryoStem Corporation (OTC Pink: CRYO), a clinical-stage therapeutics company with a proprietary end-to-end core biotechnology platform
United States John Arnone Anthony Dudzinski Kostenloser Wertpapierhandel Jersey Newsfile Corp American Cryostem Corporation
Source: finanznachrichten.de